Diker Management LLC Takeda Pharmaceutical CO LTD Transaction History

Diker Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$13.54 - $15.35 $155,114 - $175,849	-11,456 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$16.71 - $19.9 $3,342 - $3,979	-200 Reduced 1.72%	11,456 $200,000
Q1 2020 May 15, 2020	BUY	$13.02 - $20.31 $151,761 - $236,733	11,656 New	11,656 $177,000
Q4 2019 Feb 14, 2020	SELL	$16.88 - $20.83 $196,753 - $242,794	-11,656 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$16.7 - $21.52 $194,655 - $250,837	11,656 New	11,656 $237,000

337

73.8M

1.96M

165K

Ticker TAK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 3,109,050,112
Market Cap $42.2B
Description
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...

Get notified when there are updates to the investment portfolio of Diker Management LLC, based on Form 13F filings with the SEC.

Stay updated on Diker Management LLC with notifications on news.